ArticleBMC microbiology2018

Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.

Chendi Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.